NOVO NORDISK (NVO.N) CEO said the company will strengthen its diabetes treatment business and is creating a new unit focused on hematology and endocrinology.

2026-09-21

NOVO NORDISK (NVO.N) CEO said the company will strengthen its diabetes treatment business and is creating a new unit focused on hematology and endocrinology.

Other News
2026-09-21

Industry officials expect India’s 2025/26 edible oil imports to rise 3.6% to a record 16.55 mln t.

2026-09-21

On September 18th, the proportion of A-share stocks with a turnover rate below 3% slightly decreased to 71.55%, while the proportion of stocks with a turnover rate above 5% slightly rebounded from a two-year low to 14.93%, but remained below the thre